MUCOCUTANEOUS LYMPHANGIOMATOSIS AND THROMBOCYTOPENIA

Clinical trials for MUCOCUTANEOUS LYMPHANGIOMATOSIS AND THROMBOCYTOPENIA explained in plain language.

Never miss a new study

Get alerted when new MUCOCUTANEOUS LYMPHANGIOMATOSIS AND THROMBOCYTOPENIA trials appear

Sign up with your email to follow new studies for MUCOCUTANEOUS LYMPHANGIOMATOSIS AND THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Drug trial offers hope for kids with painful, disfiguring vascular growths

Disease control Completed

This study tested whether the drug sirolimus is safe and effective for treating complicated vascular anomalies in children and young adults up to age 31. These are serious, often painful growths or malformations of blood or lymph vessels that can cause disfigurement and organ pro…

Matched conditions: MUCOCUTANEOUS LYMPHANGIOMATOSIS AND THROMBOCYTOPENIA

Phase: PHASE2 • Sponsor: Denise Martin Adams • Aim: Disease control

Last updated Apr 20, 2026 16:14 UTC

MUCOCUTANEOUS LYMPHANGIOMATOSIS AND THROMBOCYTOPENIA

Get alerted when new MUCOCUTANEOUS LYMPHANGIOMATOSIS AND THROMBOCYTOPENIA trials appear

Drug trial offers hope for kids with painful, disfiguring vascular growths